CN Stock MarketDetailed Quotes

002412 Hunan Hansen Pharmaceutical

Watchlist
  • 6.07
  • +0.03+0.50%
Trading Dec 24 14:02 CST
3.05BMarket Cap13.52P/E (TTM)

About Hunan Hansen Pharmaceutical Company

The company was listed on the SME board of the Shenzhen Stock Exchange in May 2010. It was the first local company listed in Yiyang City, formerly known as Hunan Yiyang Pharmaceutical Factory. It is under the jurisdiction of Hanson Health Industry (Hunan) Co., Ltd., Hunan Hanson Pharmaceutical Research Co., Ltd., and Yunnan Yongzitang Pharmaceutical Co., Ltd. Mainly engaged in the pharmaceutical industry. The parent company mainly produces Chinese and Western pharmaceutical preparations, supplemented by chemically synthesized drugs. Leading products include Simotou oral liquid, ginkgo biloba capsules, shikuquan capsules, guaixingling capsules, fangying glucamine injections, and Chenxianglu white dew tablets. Company honors: National High-tech Enterprise, Hunan Industrial Quality Benchmark, etc. It won the “Health China Brand List” and “China's Non-prescription Drug Brand List” and won the honor of “Pharmaceutical Retail Market Potential Brand of the Year”. In December 2023, it was honored as a water efficiency leader in Hunan Province.

Company Profile

Short Name-A汉森制药
Symbol-A002412
Company NameHunan Hansen Pharmaceutical Co., Ltd
Listing DateMay 25, 2010
Issue Price35.80
Shares Offered19.00M share(s)
FoundedJan 21, 1998
Listed ExchangeSZ Stock Exchange
Legal Representativezhengqing liu
General Managerzhengqing liu
Secretaryjianghong dai
Accounting FirmChina Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
Securities Representativexiwen zhang
Legal CounselHunan Qiyuan Law Firm
Employees1394
Phone0737-6351486
Office AddressNo. 2688, Yincheng Avenue, Heshan District, Yiyang
Zip Code413000
Registered AddressNo. 2688, Yincheng Avenue, Heshan District, Yiyang City, Hunan Province
Fax0737-6351067
Emailoffice@hansenzy.com
Business License430900000005212
BusinessLicense projects: pharmaceutical production; pharmaceutical wholesale; drug retail; pharmaceutical contract production; drug import/export; drug internet information services (projects requiring approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to relevant department approval documents or licenses) General projects: production of traditional Chinese medicine extracts; medical research and development; biochemical product technology research and development; bio-based material technology research and development; class I medical device production; medical packaging material manufacturing; Class I medical device sales; Class II medical treatment Equipment sales; health care services (non-medical); investment activities with own funds; asset management services with own capital investments (with the exception of projects requiring approval according to law, independently carry out business activities based on a business license in accordance with law).

Company Executives

  • Name
  • Position
  • Salary
  • zhengqing liu
  • Chairman, Directors, President, Strategy Committee Convener
  • 1.68M
  • jianjun fu
  • Directors, VP, Member of the Remuneration and Assessment Committee
  • 328.20K
  • bingyang liu
  • Directors, Nomination Committee Members, Audit Committee Member
  • --
  • lingsong ao
  • Directors, VP, Strategy Committee Member
  • 888.20K
  • jinsong xia
  • Independent Directors, Nomination Committee Members, Audit Committee Convener
  • 70.00K
  • gaoyun hu
  • Independent Directors, Remuneration and Assessment Committee Convener, Strategy Committee Member
  • 70.00K
  • ping zhan
  • Independent Directors, Nomination Committee Convener, Member of the Remuneration and Assessment Committee, Audit Committee Member
  • 70.00K
  • jianghong dai
  • Board Secretary, VP, Chief Financial Officer
  • 284.60K
  • xiwen zhang
  • Securities Affairs Representative
  • --
  • saicheng liu
  • Chairman of the Supervisory Board, Employee Supervisors
  • 301.10K
  • renhui fu
  • Shareholder Supervisors
  • 186.90K
  • chen chen
  • Auditors
  • 26.70K
  • zhijun liu
  • VP
  • 311.80K
  • aihua liu
  • VP
  • 311.70K
  • hua yang
  • VP
  • 324.60K
  • bo yang
  • Head of Internal Audit
  • --